Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Anaptysbio Inc (NQ: ANAB ) 22.11 +0.48 (+2.22%) Streaming Delayed Price Updated: 3:01 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Anaptysbio Inc < Previous 1 2 3 4 Next > AnaptysBio To Discontinue Imsidolimab Development In Moderate-to-Severe Acne March 15, 2022 AnaptysBio Inc's (NASDAQ: ANAB) Phase 2 ACORN trial of imsidolimab for moderate-to-severe acne Via Benzinga The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial March 15, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session March 14, 2022 Gainers Sigilon Therapeutics (NASDAQ:SGTX) stock rose 15.5% to $1.49 during Monday's after-market session. The market value of their outstanding shares is at $48.1 million. Via Benzinga AnaptysBio's Return On Capital Employed Insights March 10, 2022 AnaptysBio (NASDAQ:ANAB) brought in sales totaling $1.01 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 388.12%, resulting in a loss of... Via Benzinga Recap: AnaptysBio Q4 Earnings March 07, 2022 AnaptysBio (NASDAQ:ANAB) reported its Q4 earnings results on Monday, March 7, 2022 at 09:00 AM. Here's what investors need to know about the announcement. Earnings... Via Benzinga The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline August 18, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety Hoth Therapeutics Reports Being Set To Begin Phase 2 Study On First-Of-Its-Kind Skin Toxicity Ointment For Cancer Patients February 01, 2022 Image provided by Pexels This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Via Benzinga The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children October 26, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Anaptys Sells Royalties Due On Cancer Drug Jemperli To Sagard For $250M... Via Benzinga AnaptysBio Reveals Updated Imsidolimab Data In Severe Form Of Psoriasis October 04, 2021 AnaptysBio Inc (NASDAQ: ANAB) has announced updated data from the GALLOP Phase 2 trial of imsidolimab in generalized pustular psoriasis (GPP). GPP is a rare and... Via Benzinga AnaptysBio-Generated Antibody Scores Second FDA Approval For Solid Tumor Indication August 18, 2021 The FDA has approved a second indication for GlaxoSmithKline plc's (NYSE: GSK) Jemperli (dostarlimab-gxly). The approval comes for adult patients with... Via Benzinga Exposures Product Safety Benzinga's Top Ratings Upgrades, Downgrades For May 21, 2021 May 21, 2021 Upgrades According to JP Morgan, the prior rating for ResMed Inc (NYSE:RMD) was changed from Neutral to Overweight. For the third quarter, ResMed had an EPS of $1.30,... Via Benzinga The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics, And More May 08, 2021 Insider buying can be an encouraging signal for investors, especially when markets are near all-time highs. Some insiders have taken advantage of initial public offerings. A few chief executive... Via Talk Markets The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics And More May 08, 2021 Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Once again, some insiders have taken advantage of initial... Via Benzinga Last Week's Notable Insider Buys: Beacon Roofing, Chipotle, IPOs, Latham And More May 02, 2021 Here are some of the most noteworthy insider purchases that were reported in the past week. Via Talk Markets Last Week's Notable Insider Buys: Beacon Roofing, Chipotle, IPOs, Latham And More May 02, 2021 Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Once again, some insiders took advantage of recent public... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
